N,N-dibenzyl-2-bromoethanamine → HCID 131710085, 화합물

반응식

[CH2:1]([N:8]([CH2:28]C1C=CC=CC=1)[CH2:9][CH2:10][N:11]1[C:20]2[C:15](=[CH:16][CH:17]=[C:18]([CH3:21])[N:19]=2)[C:14](=[O:22])[C:13]([C:23]([O:25][CH2:26][CH3:27])=[O:24])=[CH:12]1)C1C=CC=CC=1.C(N(CC1C=CC=CC=1)CCBr)C1C=CC=CC=1>>[CH3:28][N:8]([CH3:1])[CH2:9][CH2:10][N:11]1[C:20]2[C:15](=[CH:16][CH:17]=[C:18]([CH3:21])[N:19]=2)[C:14](=[O:22])[C:13]([C:23]([O:25][CH2:26][CH3:27])=[O:24])=[CH:12]1

참가 물질

반응물 2

HCID 14378N,N-dibenzyl-2-bromoethanamine

HCID 131710086HCID 131710086, 화합물

생성물 1

HCID 131710085HCID 131710085, 화합물

실험 절차

1-[2-(Dibenzylamino)ethyl]-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid, ethyl ester, m.p. 170°-174° (72 %) (2-Dibenzylaminoethyl bromide).

출처 및 근거

ORD 기록: ord-3812b6511f3c4cd98d053c7526919f59
출처 데이터셋: uspto-grants-1976_03
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US03943141

반응 노트

불러오는 중…